agilon health(US:AGL) TMX Newsfile·2026-02-07 14:56Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. due to alleged violations of federal securities laws, encouraging affected investors to contact them for legal options [2][4]. Group 1: Legal Investigation - The law firm is reminding investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action against agilon health [2]. - The complaint alleges that agilon health and its executives made false or misleading statements regarding the company's financial guidance for 2025, which they knew was unattainable due to industry challenges [4]. Group 2: Financial Impact - On August 4, 2025, agilon health announced the suspension of its full-year 2025 financial guidance, leading to a significant stock price drop of 51.5% on August 5, 2025 [5]. - The complaint claims that the defendants overstated the financial benefits from strategic actions taken to mitigate risks, resulting in materially false statements about the company's business and prospects [4]. Group 3: Firm Background - Faruqi & Faruqi, LLP has recovered hundreds of millions of dollars for investors since its establishment in 1995 and has offices in New York, Pennsylvania, California, and Georgia [3].